These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22090181)

  • 21. Femoro-femoral arterial bypass is an effective and durable treatment for symptomatic unilateral iliac artery occlusion.
    Pai M; Handa A; Hands L; Collin J
    Ann R Coll Surg Engl; 2003 Mar; 85(2):88-90. PubMed ID: 12648336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Femorofemoral bypass as an alternative to a direct aortic approach in daily practice: appraisal of its current indications and midterm results.
    Rinckenbach S; Guelle N; Lillaz J; Al Sayed M; Ritucci V; Camelot G
    Ann Vasc Surg; 2012 Apr; 26(3):359-64. PubMed ID: 22050878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting.
    Timaran CH; Stevens SL; Grandas OH; Piercy KT; Freeman MB; Goldman MH
    J Vasc Surg; 2000 Sep; 32(3):506-16; 516-8. PubMed ID: 10957657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of revised lower-extremity bypass grafts.
    Landry GJ; Moneta GL; Taylor LM; Edwards JM; Yeager RA; Porter JM
    J Vasc Surg; 2002 Jan; 35(1):56-62; discussion 62-3. PubMed ID: 11802133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iliofemoral bypass: a 10-year review.
    Oliveira M; Wilson SE; Williams R; Freischlag JA
    Cardiovasc Surg; 1993 Apr; 1(2):103-6. PubMed ID: 8076008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patency and limb salvage rates after distal revascularization to unclampable calcified outflow arteries.
    Ballotta E; Renon L; Toffano M; Piccoli A; Da Giau G
    J Vasc Surg; 2004 Mar; 39(3):539-46. PubMed ID: 14981445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience.
    Kudo T; Chandra FA; Ahn SS
    J Vasc Surg; 2005 Mar; 41(3):423-35; discussion 435. PubMed ID: 15838475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of unilateral iliac artery disease by femorofemoral bypass grafting.
    Sheiner NM; Ashby D; Zeltzer J
    Can J Surg; 1979 Sep; 22(5):474-6. PubMed ID: 159115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High recurrence rate following axillofemoral bypass: is continued use still justified?].
    Hepp W; Pallua N
    Zentralbl Chir; 1985; 110(18):1138-46. PubMed ID: 4082804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.
    Donker JM; Ho GH; Te Slaa A; de Groot HG; van der Waal JC; Veen EJ; van der Laan L
    Vasc Endovascular Surg; 2011 Oct; 45(7):598-603. PubMed ID: 21757494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External iliac and common iliac artery angioplasty and stenting in men and women.
    Timaran CH; Stevens SL; Freeman MB; Goldman MH
    J Vasc Surg; 2001 Sep; 34(3):440-6. PubMed ID: 11533595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multilevel bypass grafting: is it worth it?
    Sharples A; Kay M; Sykes T; Fox A; Houghton A
    Ann Vasc Surg; 2014 Oct; 28(7):1697-702. PubMed ID: 24704851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is femorofemoral crossover bypass an option in claudication?
    Capoccia L; Riambau V; da Rocha M
    Ann Vasc Surg; 2010 Aug; 24(6):828-32. PubMed ID: 20638622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aortoiliac insufficiency: long-term experience with stent placement for treatment.
    Murphy TP; Ariaratnam NS; Carney WI; Marcaccio EJ; Slaiby JM; Soares GM; Kim HM
    Radiology; 2004 Apr; 231(1):243-9. PubMed ID: 15068949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of iliac wallstents.
    Reyes R; Carreira JM; Gude F; Górriz E; Gallardo L; Pardo MD; Hermida M
    Cardiovasc Intervent Radiol; 2004; 27(6):624-31. PubMed ID: 15578139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of axillofemoral by-passes for aorto-iliac occlusive disease.
    Illuminati G; Calio FG; Mangialardi N; Bertagni A; Vietri F; Martinelli V
    Langenbecks Arch Chir; 1996; 381(4):212-7. PubMed ID: 8817447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of primary aortic graft infection by extra-anatomic bypass reconstruction.
    Lehnert T; Gruber HP; Maeder N; Allenberg JR
    Eur J Vasc Surg; 1993 May; 7(3):301-7. PubMed ID: 8513910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Femorofemoral versus aortobifemoral bypass: outcome and hemodynamic results.
    Schneider JR; Besso SR; Walsh DB; Zwolak RM; Cronenwett JL
    J Vasc Surg; 1994 Jan; 19(1):43-55; discussion 55-7. PubMed ID: 8301737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the iliac artery a suitable inflow conduit for iliofemoral occlusive disease: an analysis of 514 aortoiliac reconstructions.
    Darling RC; Leather RP; Chang BB; Lloyd WE; Shah DM
    J Vasc Surg; 1993 Jan; 17(1):15-9; discussion 19-22. PubMed ID: 8421331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of iliac artery stent deployment.
    Ballard JL; Sparks SR; Taylor FC; Bergan JJ; Smith DC; Bunt TJ; Killeen JD
    J Vasc Surg; 1996 Oct; 24(4):545-53; discussion 553-5. PubMed ID: 8911403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.